UAE Oxygen Concentrators Market By Type (Portable, Stationary), By Technology (Pulse Flow, Continuous Flow, Continuous/Pulse), By Flow-rate (0-51/min, 5-101/min, Above 101/min), By Distribution Channel (Wholesalers/Distributors/Suppliers, Online, Direct Sales), By Offering (Rental, New Sales), By Application (COPD, Lung Cancer, Asthma, COVID-19, Others), By End Users (Hospitals & Clinics, Ambulatory Care Centers, Home Care, Others), By Region, Competition, Forecast & Opportunities, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 23.12 Million
CAGR (2026-2031)	5.14%
Fastest Growing Segment	Portable
Largest Market	Abu Dhabi
Market Size (2031)	USD 31.23 Million

Market Overview

The UAE Oxygen Concentrators Market will grow from USD 23.12 Million in 2025 to USD 31.23 Million by 2031 at a 5.14% CAGR. Oxygen concentrators are medical devices designed to concentrate oxygen from a gas supply, typically ambient air, by selectively removing nitrogen to supply an oxygen-enriched product gas stream to patients. The primary drivers supporting the UAE market’s growth include the rising prevalence of chronic respiratory disorders, such as asthma and COPD, and a demographic shift toward an aging population necessitating long-term home care. Furthermore, the government's strategic focus on expanding healthcare infrastructure and enhancing the quality of medical services significantly strengthens demand, acting as a robust foundation distinct from transient market trends.

To support this expanding infrastructure and health priority, according to the UAE Cabinet, in 2025, AED 5.745 billion was allocated to healthcare and community prevention services, representing 8 percent of the total federal budget. This substantial financial commitment underscores the stable environment for medical device procurement. However, a significant challenge impeding market expansion is the region's high dependency on imports, which leaves the local supply chain vulnerable to global logistical disruptions and potential inventory shortages during periods of peak demand.

Key Market Drivers

The Rising Prevalence of Chronic Respiratory Disorders stands as a primary catalyst for the UAE Oxygen Concentrators Market, fundamentally driven by environmental factors and lifestyle variables that necessitate long-term respiratory support. The region's exposure to dust storms and rapid urbanization contributes to a high incidence of conditions such as asthma and chronic obstructive pulmonary disease (COPD), directly increasing the clinical requirement for supplemental oxygen. According to Aletihad, in March 2025, the 2024 World Air Quality Report revealed that the UAE's PM2.5 concentration stood at 33.7 micrograms per cubic meter, a level that continues to pose respiratory health risks despite recent improvements. This environmental burden correlates with a surging demand for medical intervention across the emirates. For instance, according to Burjeel Holdings, in March 2025, the healthcare group reported a total patient footfall of 6.5 million for the fiscal year 2024, highlighting the escalating volume of patients seeking medical care, including respiratory treatments, within the network.

Strategic Government Investments in Healthcare Infrastructure further propel market expansion, as state-backed entities and private providers aggressively scale their capabilities to meet this growing demand. These investments ensure the steady procurement of advanced medical devices, including oxygen concentrators, to equip new hospitals and specialized care centers. This expansion is characterized by significant financial growth among leading national providers, ensuring a stable funding environment for equipment acquisition. According to PureHealth, in February 2025, the organization announced a 58 percent increase in annual revenue to AED 25.8 billion, underscoring the rapid development of the national healthcare ecosystem which supports the widespread adoption of essential medical technologies. This robust infrastructural growth guarantees that the supply chain for respiratory devices remains a priority for both government and private health sectors.

Download Free Sample Report

Key Market Challenges

The region's acute reliance on imported medical devices stands as a formidable barrier to the sustained expansion of the UAE Oxygen Concentrators Market. Since domestic manufacturing capabilities for specialized respiratory equipment remain limited, distributors and healthcare providers depend heavily on international manufacturers to meet local requirements. This structural dependency creates a fragile supply chain where global logistical disruptions—ranging from shipping delays to raw material shortages—directly translate into local inventory deficits. Consequently, during periods of heightened respiratory illness or sudden demand surges, the inability to rapidly source oxygen concentrators restricts market expansion and compromises patient care delivery.

This vulnerability is particularly critical given the sector's substantial economic footprint. According to Mecomed (Medical Technology Association in the Middle East & North Africa), the UAE medical device market was projected to reach a value of US$ 3.02 billion in 2024. Such a significant market valuation exposes the high financial risk associated with supply interruptions; when imported units are delayed, potential revenue realization is stalled, and the market's overall growth trajectory is flattened despite robust demand drivers. Without a localized production buffer, the market remains tethered to external variables, limiting its ability to sustain consistent growth momentum.

Key Market Trends

The Expansion of Home-Based Oxygen Therapy Service Models is fundamentally reshaping the market landscape as healthcare providers prioritize outpatient care over traditional hospital admissions. This shift is driven by the need to optimize hospital resources and improve patient quality of life, leading to a surge in demand for respiratory devices suitable for home environments. As healthcare networks expand their community reach, patients are increasingly managed through remote and day-care frameworks rather than inpatient stays, creating a sustained requirement for durable home medical equipment. According to Emirates News Agency (WAM), November 2025, in the 'PureHealth posts AED1.55 billion profit for first nine months of 2025' report, the organization recorded a 12 percent increase in outpatient volumes across its network, highlighting the rapid transition toward non-acute care settings which directly fuels the procurement of home-based oxygen solutions.

Concurrently, the Integration of Smart Connectivity and Remote Monitoring Systems is transforming oxygen concentrators from standalone units into connected elements of a digital health ecosystem. Manufacturers and providers are increasingly focusing on devices that can transmit real-time patient data, enabling timely clinical interventions and enhancing adherence to therapy protocols. This trend is accelerated by the widespread adoption of digital health platforms that link patients directly with care providers for continuous oversight, creating a technological infrastructure that supports smart device deployment. According to PureHealth, July 2025, in the 'H1 2025 Financial Results' report, the company’s digital engagement platform surpassed 620,000 users, demonstrating the massive scale of digital adoption that underpins the growing market requirement for connected respiratory technologies.

Segmental Insights

The portable segment is currently the fastest-growing category in the UAE oxygen concentrators market, driven by a rising preference for home healthcare and patient mobility. As the Ministry of Health and Prevention continues to endorse community-based care models, there is a tangible shift toward devices that facilitate treatment outside traditional hospital environments. Patients requiring long-term respiratory support increasingly favor lightweight units that permit travel and daily activities. This trend reflects a broader market evolution where operational flexibility and ease of transport are primary considerations for effective chronic disease management.

Regional Insights

Abu Dhabi maintains the leading position in the UAE oxygen concentrators market due to extensive investments in healthcare infrastructure and favorable government policies. This dominance is largely driven by the strategic initiatives of the Department of Health – Abu Dhabi, which prioritizes the effective management of chronic respiratory diseases and the expansion of home healthcare services. The region benefits from a high concentration of specialized medical facilities that require reliable respiratory support systems. These regulatory frameworks and infrastructural developments create a stable environment that supports higher adoption rates relative to other emirates.

Recent Developments

• In January 2025, the Yuwell Group signed a strategic investment and cooperation agreement with Inogen, a United States-based oxygen concentrator manufacturer, in Dubai. The partnership, finalized ahead of the Arab Health 2025 exhibition, aims to accelerate the global adoption of high-quality respiratory products and advance the healthcare sector worldwide. This collaboration leverages Yuwell's manufacturing capabilities and Inogen's technology to expand the reach of their oxygen therapy solutions across the Middle East and international markets.
• In January 2024, Drive DeVilbiss Healthcare partnered with Sanrai International to unveil the PulmO2 oxygen concentrator at the Arab Health exhibition in Dubai. This new device was engineered specifically to address the needs of low-resource environments, featuring energy-saving capabilities that reduce power consumption by up to 64% compared to traditional 10-liter concentrators. The launch highlighted the companies' collaborative effort to provide robust and resilient respiratory solutions for markets with challenging power and environmental conditions.
• In January 2024, GCE Medical, a brand of ESAB Corporation, showcased its comprehensive portfolio of gas control equipment, including the Zen-O portable oxygen concentrator, at the Arab Health exhibition in Dubai. The company presented the device as a best-in-class solution offering both pulse and continuous oxygen delivery modes designed for active patients. This event marked the launch of GCE Medical's full global offering, emphasizing their commitment to meeting international compliance standards and supporting homecare and hospital needs in the region.
• In January 2024, Canta Medical showcased its flagship oxygen production solutions, including the HPT-10 oxygen concentrator, at the Arab Health exhibition in Dubai. The company used the platform to demonstrate its latest advancements in household and medical oxygen production to industry professionals and buyers from the Middle East and North Africa. The exhibition served as a significant venue for the manufacturer to present its diverse series of oxygen concentrators and hyperbaric chambers, reinforcing its presence in the regional market.

Key Market Players

• Philips Healthcare Middle East
• Atlas Medical LLC
• Invacare Corp (UAE)
• GCE Group (UAE)
• Drive DeVilbiss Healthcare

By Type	By Technology	By Flow-rate	By Distribution Channel	By Offering	By Application	By End Users	By Region
Portable Stationary	Pulse Flow Continuous Flow Continuous/Pulse	0-51/min 5-101/min Above 101/min	Wholesalers/Distributors/Suppliers Online Direct Sales	Rental New Sales	COPD Lung Cancer Asthma COVID-19 Others	Hospitals & Clinics Ambulatory Care Centers Home Care Others	Dubai Abu Dhabi Sharjah Rest of UAE

Report Scope:

In this report, the UAE Oxygen Concentrators Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• UAE Oxygen Concentrators Market, By Type:

• Portable
• Stationary

• UAE Oxygen Concentrators Market, By Technology:

• Pulse Flow
• Continuous Flow
• Continuous/Pulse

• UAE Oxygen Concentrators Market, By Flow-rate:

• 0-51/min
• 5-101/min
• Above 101/min

• UAE Oxygen Concentrators Market, By Distribution Channel:

• Wholesalers/Distributors/Suppliers
• Online
• Direct Sales

• UAE Oxygen Concentrators Market, By Offering:

• Rental
• New Sales

• UAE Oxygen Concentrators Market, By Application:

• COPD
• Lung Cancer
• Asthma
• COVID-19
• Others

• UAE Oxygen Concentrators Market, By End Users:

• Hospitals & Clinics
• Ambulatory Care Centers
• Home Care
• Others

• UAE Oxygen Concentrators Market, By Region:

• Dubai
• Abu Dhabi
• Sharjah
• Rest of UAE